View drug registration information details.


ItemsRegistration information
ID273
No273
Brand NameCLAMOVID 625
IngredientsAMOXICILLIN TRIHYDRATE 588.2 MG EQ.TO AMOXICILLIN 500 MG, POTASSIUM CLAVULANATE + MICROCRYSTALLINE CELLULOSE 1:1 302.3 MG EQ.TO CLAVULANIC ACID 125 MG
Dosage FormTABLET
Primary PackagingALU-ALU BLISTER
StorageSTORE BELOW 25 C
Shelf Life3 YEARS
Pack SizeBLISTER OF 3 X 5 TABLETS
Dispensing CategoryPrescription only
ATC ClassificationJ01CA04
Pharmaceutical ClassANTIBACTERIAL COMBINATIONS
IndicationsFOR THE TREATMENT OF ACUTE OTITIS MEDIA, SINUSITIS, PNEUMONIA, SKIN AND SOFT TISSUE INFECTIONS, URINARY TRACT INFECTIONS CAUSED BY BETA LACTAMASE-PRODUCING STRAINS OF BACTERIA
ContraindicationsHYPERSENSITIVITY, PREVIOUS HISTORY OF PENICILIN-ASSOCIATED JAUNDICE/HEPATIC DYSFUNCTION, PATIENTS WITH INFECTIOUS MONONUCLEOSIS
Side EffectsDIARRHOEA, INDIGESTION, NAUSEA, VOMITING, AND MUCOCUTANEOUS CANDIDIASIS, VAGINAKL ITCHING, SORENESS AND DISCHARGE
Unit Price-
EDL Yes
DescriptionOBLONG, WHITE, FILM COATED TABLET WITH SHALLOW CONVEX FACES.
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerBILIM ILAC SANAYI VE TICARET A.S.
CountryMALAYSIA
Import Registration NoMAL20002448ACZ
Import Registration Date2010-12-23
ActivityCERTIFICATE RELEASED
Applied Date2024-12-25
FDD Registration No11 I 4630/18
FDD Registration Date2025-01-16
Expiry Date2030-01-15

Back to drug list